Jule Taubmann
Impact in
-
- CAR-T cell therapy research
- Bone health and treatments
-
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Biosimilars and Bioanalytical Methods
Papers in
- Oncology 10
- CAR-T cell therapy research 9
-
- Biosimilars and Bioanalytical Methods 3
- T-cell and B-cell Immunology 3
- Immunodeficiency and Autoimmune Disorders 2
- Co-authors
- Georg Schett (14 shared papers)Andréas Mackensen (10 shared papers)Fabian Müller (7 shared papers)Dimitrios Mougiakakos (4 shared papers)Michael Aigner (6 shared papers)Simon Völkl (5 shared papers)Franco Locatelli (1 shared paper)Carl H. June (1 shared paper)
- Journals
- Scientific Reports (2 papers)Lara D. Veeken (2 papers)Blood (1 paper)Nature Medicine (1 paper)Frontiers in Medicine (1 paper)
- Partner nations
- GermanyItalyUnited Kingdom
In The Last Decade
Jule Taubmann
15 papers receiving 304 citations
Jule Taubmann's Hit Papers
Peers
Comparison fields: 5 of 60
- Oncology 176
- Immunology 99
- Health Informatics 5
- Rheumatology 41
- Genetics 26
Countries citing papers authored by Jule Taubmann
This map shows the geographic impact of Jule Taubmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jule Taubmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jule Taubmann more than expected).
Fields of papers citing papers by Jule Taubmann
This network shows the impact of papers produced by Jule Taubmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jule Taubmann. The network helps show where Jule Taubmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Jule Taubmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Advancements and challenges in CAR T cell therapy in autoimmune diseases Hit paper breakdown → | 2024 | 85 |
| 2 | 2023 | 55 | |
| 3 | 2020 | 47 | |
| 4 | 2023 | 37 | |
| 5 | 2023 | 19 | |
| 6 | 2020 | 19 | |
| 7 | BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells Hit paper breakdown → | 2025 | 15 |
| 8 | 2024 | 9 | |
| 9 | 2023 | 9 | |
| 10 | 2025 | 5 | |
| 11 | 2025 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2025 | 0 |
About Jule Taubmann
Jule Taubmann is a scholar working on Oncology, Immunology, Molecular Biology, Epidemiology and Rheumatology, having authored 16 papers that have together received 308 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Biosimilars and Bioanalytical Methods (3 papers), T-cell and B-cell Immunology (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Inflammatory Myopathies and Dermatomyositis (3 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (176 citations), Immunology (99 citations), Health Informatics (5 citations), Rheumatology (41 citations) and Genetics (26 citations). Jule Taubmann has collaborated with scholars based in Germany, Italy and United Kingdom. Frequent co-authors include Georg Schett, Andréas Mackensen, Fabian Müller, Dimitrios Mougiakakos, Michael Aigner, Simon Völkl, Franco Locatelli, Carl H. June, Johannes Knitza and Wei Wang. Their work appears in journals such as Scientific Reports, Lara D. Veeken, Blood, Nature Medicine and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.